4.7 Letter

Intense immunosuppression for the treatment of an immune reconstitution inflammatory syndrome-like exacerbation after natalizumab withdrawal: a case report

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

What to expect after natalizumab cessation in a real-life setting

S. Salhofer-Polanyi et al.

ACTA NEUROLOGICA SCANDINAVICA (2014)

Article Clinical Neurology

Fingolimod after natalizumab and the risk of short-term relapse

Vilija G. Jokubaitis et al.

NEUROLOGY (2014)

Article Clinical Neurology

Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study

G. Borriello et al.

EUROPEAN JOURNAL OF NEUROLOGY (2012)

Review Clinical Neurology

Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab

B. K. Kleinschmidt-DeMasters et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)

Article Clinical Neurology

Severe multiple sclerosis reactivation under fingolimod 3 months after natalizumab withdrawal

L. Daelman et al.

MULTIPLE SCLEROSIS JOURNAL (2012)

Editorial Material Clinical Neurology

LETHAL MULTIPLE SCLEROSIS RELAPSE AFTER NATALIZUMAB WITHDRAWAL

Valerie Rigau et al.

NEUROLOGY (2012)

Article Clinical Neurology

Immune reconstitution inflammatory syndrome in natalizumab-associated PML

I. L. Tan et al.

NEUROLOGY (2011)

Editorial Material Clinical Neurology

IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME AFTER WITHDRAWAL OF NATALIZUMAB?

T. Lenhard et al.

NEUROLOGY (2010)